Detalhe da pesquisa
1.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
N Engl J Med
; 388(15): 1353-1364, 2023 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36876740
2.
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.
JAMA
; 330(2): 131-140, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354546
3.
Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
Circulation
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581406
4.
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
JAMA
; 316(22): 2373-2384, 2016 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27846344
5.
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
JAMA
; 315(15): 1580-90, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27039291
6.
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Am Heart J
; 169(2): 257-265.e1, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25641535
7.
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
Eur Heart J
; 35(37): 2516-23, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24796339
8.
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.
JAMA
; 311(3): 252-62, 2014 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24247616
9.
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial.
Lancet Diabetes Endocrinol
; 12(1): 19-28, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061370
10.
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial.
JAMA Cardiol
; 9(3): 245-253, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231501
11.
Treatment strategies in patients with statin intolerance: the Cleveland Clinic experience.
Am Heart J
; 166(3): 597-603, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24016512
12.
Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers.
J Am Coll Cardiol
; 81(1): 1-12, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351465
13.
Impact of exercise on heart rate recovery.
Circulation
; 124(14): 1520-6, 2011 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21947293
14.
Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Circulation
; 121(23): 2575-83, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20516378
15.
Comprehensive peroxidase-based hematologic profiling for the prediction of 1-year myocardial infarction and death.
Circulation
; 122(1): 70-9, 2010 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-20566956
16.
The impact of left ventricular size on response to cardiac resynchronization therapy.
Am Heart J
; 162(4): 646-53, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21982656
17.
Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.
Clin Chem
; 57(12): 1762-70, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21940659
18.
Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation.
Arterioscler Thromb Vasc Biol
; 30(3): 634-40, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20032289
19.
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis.
Eur Heart J
; 31(10): 1257-65, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20181681
20.
Erratum to "C-Reactive Protein Levels and Plaque Regression with Evolocumab: Insights From GLAGOV" [American Journal of Preventive Cardiology 3C (2020) 100091].
Am J Prev Cardiol
; 6: 100153, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374706